| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Deborah S Hasi. US Epidemiology of Cannabis Use and Associated Problems. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 43. issue 1. 2018-07-26. PMID:28853439. |
however, the more limited literature suggests that mmls have led to increased cannabis potency, unintentional childhood exposures, adult cannabis use, and adult cud. |
2018-07-26 |
2023-08-13 |
Not clear |
| Christina A Brezing, Frances R Levi. The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 43. issue 1. 2018-07-26. PMID:28875989. |
cannabis use disorder (cud) commonly occurs and carries a notable economic and functional burden at both individual and societal levels. |
2018-07-26 |
2023-08-13 |
human |
| Christina A Brezing, Frances R Levi. The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 43. issue 1. 2018-07-26. PMID:28875989. |
while there are no clearly efficacious medication treatments for cud, 20 years of committed and high-quality research in the human laboratory and clinical settings have resulted in medications with demonstrated effectiveness in the treatment of cannabis withdrawal, the ability to reduce cannabis use, and results that point to promising future work. |
2018-07-26 |
2023-08-13 |
human |
| Christina A Brezing, Frances R Levi. The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 43. issue 1. 2018-07-26. PMID:28875989. |
the current state of pharmacology research for cud highlights the need to consider particular characteristics of patients, such as gender, impulsivity, and severity of cannabis use, when selecting a medication in the off-label treatment of cud or cannabis withdrawal. |
2018-07-26 |
2023-08-13 |
human |
| Bradley T Kerridge, Roger Pickering, Patricia Chou, Tulshi D Saha, Deborah S Hasi. DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and Related Conditions-III: Gender-specific profiles. Addictive behaviors. vol 76. 2018-06-14. PMID:28755613. |
the objective of this study was to present current information on the prevalence, correlates, comorbidity and quality of life among men and women with cannabis use disorder (cud). |
2018-06-14 |
2023-08-13 |
Not clear |
| Isaac C Rhew, Charles B Fleming, Ann Vander Stoep, Semret Nicodimos, Cheng Zheng, Elizabeth McCaule. Examination of cumulative effects of early adolescent depression on cannabis and alcohol use disorder in late adolescence in a community-based cohort. Addiction (Abingdon, England). vol 112. issue 11. 2018-06-12. PMID:28600897. |
this study estimated the effects of cumulative depression during early adolescence (ages 13-15 years) on the likelihood of cannabis use disorder (cud) and alcohol use disorder (aud) at age 18. |
2018-06-12 |
2023-08-13 |
Not clear |
| C Ouellet-Plamondon, A Abdel-Baki, É Salvat, S Potvi. Specific impact of stimulant, alcohol and cannabis use disorders on first-episode psychosis: 2-year functional and symptomatic outcomes. Psychological medicine. vol 47. issue 14. 2018-05-28. PMID:28424105. |
many studies have concluded that cannabis use disorder (cud) negatively influences outcomes in first-episode psychosis (fep). |
2018-05-28 |
2023-08-13 |
Not clear |
| He Zhu, Li-Tzy W. Sex Differences in Cannabis Use Disorder Diagnosis Involved Hospitalizations in the United States. Journal of addiction medicine. vol 11. issue 5. 2018-05-28. PMID:28700366. |
the study examined sex differences in trend and clinical characteristics of cannabis use disorder (cud) diagnosis involved hospitalizations among adult patients. |
2018-05-28 |
2023-08-13 |
Not clear |
| Bradley T Kerridge, Pia M Mauro, S Patricia Chou, Tulshi D Saha, Roger P Pickering, Amy Z Fan, Bridget F Grant, Deborah S Hasi. Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States. Drug and alcohol dependence. vol 181. 2018-05-23. PMID:29107786. |
to present information on predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime dsm-5 cannabis use disorder (cud). |
2018-05-23 |
2023-08-13 |
Not clear |
| Amie C Hayley, Con Stough, Luke A Downe. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 27. issue 8. 2018-04-18. PMID:28663122. |
cannabis use disorder (cud) is frequently associated with concurrent substance use and/or comorbid substance use disorders (suds); however there is little specificity with regard to commonly abused individual drug types/classes. |
2018-04-18 |
2023-08-13 |
Not clear |
| William S John, Li-Tzy W. Problem alcohol use and healthcare utilization among persons with cannabis use disorder in the United States. Drug and alcohol dependence. vol 178. 2018-04-03. PMID:28711814. |
the emergency department (ed) and hospital settings represent crucial opportunities for engaging treatment for cannabis use disorder (cud). |
2018-04-03 |
2023-08-13 |
Not clear |
| Anne Buu, Yi-Han Hu, Sanjana Pampati, Brooke J Arterberry, Hsien-Chang Li. Predictive validity of cannabis consumption measures: Results from a national longitudinal study. Addictive behaviors. vol 73. 2018-04-02. PMID:28463803. |
validating the utility of cannabis consumption measures for predicting later cannabis related symptomatology or progression to cannabis use disorder (cud) is crucial for prevention and intervention work that may use consumption measures for quick screening. |
2018-04-02 |
2023-08-13 |
Not clear |
| Anne Buu, Yi-Han Hu, Sanjana Pampati, Brooke J Arterberry, Hsien-Chang Li. Predictive validity of cannabis consumption measures: Results from a national longitudinal study. Addictive behaviors. vol 73. 2018-04-02. PMID:28463803. |
this study examined whether cannabis use quantity and frequency predicted cud symptom counts, progression to onset of cud, and persistence of cud. |
2018-04-02 |
2023-08-13 |
Not clear |
| Lesia M Ruglass, Alina Shevorykin, Christina Brezing, Mei-Chen Hu, Denise A Hie. Demographic and clinical characteristics of treatment seeking women with full and subthreshold PTSD and concurrent cannabis and cocaine use disorders. Journal of substance abuse treatment. vol 80. 2018-04-02. PMID:28755772. |
women with full or subthreshold ptsd and co-occurring cannabis use disorder (cud) and cocaine use disorder (cod; n=99) were compared to their counterparts with co-occurring cud only (n=26) and co-occurring cod only (n=161) on rates of trauma exposure, psychiatric disorders, psychosocial problems, and other substance use utilizing a set of multivariate logistic regressions. |
2018-04-02 |
2023-08-13 |
Not clear |
| M Smolkina, K I Morley, F Rijsdijk, A Agrawal, J E Bergin, E C Nelson, D Statham, N G Martin, M T Lynske. Cannabis and Depression: A Twin Model Approach to Co-morbidity. Behavior genetics. vol 47. issue 4. 2018-03-22. PMID:28466235. |
cannabis use disorder (cud) co-occurs with major depressive disorder (mdd) more frequently than would be expected by chance. |
2018-03-22 |
2023-08-13 |
Not clear |
| Li-Tzy Wu, He Zhu, Paolo Mannelli, Marvin S Swart. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States. Drug and alcohol dependence. vol 177. 2018-03-19. PMID:28599214. |
the increase in cannabis potency may have treatment implications for cannabis use disorder (cud). |
2018-03-19 |
2023-08-13 |
Not clear |
| Li-Tzy Wu, He Zhu, Paolo Mannelli, Marvin S Swart. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States. Drug and alcohol dependence. vol 177. 2018-03-19. PMID:28599214. |
given the reported increase in prevalence of cannabis use among adults, there is a need to understand substance use treatment needs for cud. |
2018-03-19 |
2023-08-13 |
Not clear |
| Kevin M Gray, Susan C Sonne, Erin A McClure, Udi E Ghitza, Abigail G Matthews, Aimee L McRae-Clark, Kathleen M Carroll, Jennifer S Potter, Katharina Wiest, Larissa J Mooney, Albert Hasson, Sharon L Walsh, Michelle R Lofwall, Shanna Babalonis, Robert W Lindblad, Steven Sparenborg, Aimee Wahle, Jacqueline S King, Nathaniel L Baker, Rachel L Tomko, Louise F Haynes, Ryan G Vandrey, Frances R Levi. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug and alcohol dependence. vol 177. 2018-03-12. PMID:28623823. |
cannabis use disorder (cud) is a prevalent and impairing condition, and established psychosocial treatments convey limited efficacy. |
2018-03-12 |
2023-08-13 |
Not clear |
| Derek B Kosty, John R Seeley, Richard F Farmer, Joseph J Stevens, Peter M Lewinsoh. Trajectories of cannabis use disorder: risk factors, clinical characteristics and outcomes. Addiction (Abingdon, England). vol 112. issue 2. 2018-02-22. PMID:27515021. |
to estimate cannabis use disorder (cud) trajectory classes from ages 14 to 30 years and compare classes on clinical characteristics, risk factors and psychosocial outcomes. |
2018-02-22 |
2023-08-13 |
Not clear |
| Jose M Trigo, Alexandra Soliman, Lena C Quilty, Benedikt Fischer, Jürgen Rehm, Peter Selby, Allan J Barnes, Marilyn A Huestis, Tony P George, David L Streiner, Gregory Staios, Bernard Le Fol. Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial. PloS one. vol 13. issue 1. 2018-02-21. PMID:29385147. |
the current lack of pharmacological treatments for cannabis use disorder (cud) warrants novel approaches and further investigation of promising pharmacotherapy. |
2018-02-21 |
2023-08-13 |
human |